CCTV exposed white-label manufacturers such as Bai Ai Shen for exceeding limits in adding banned pesticides to mosquito repellent products, profiting at the expense of children's health, now facing severe regulatory and legal penalties.
As temperatures fully enter the mid-2026 summer peak, the mosquito prevention and repellent sector—a staple consumer market—should have been entering its golden profit surge period. Instead, it has been stripped of its last shred of dignity by a targeted exposé from mainstream media and regulators. Recently, CCTV and other authoritative media outlets zeroed in on regulatory loopholes and fraudulent manufacturing practices in the mosquito repellent industry, directly naming two white-label contract manufacturers: Guangzhou Bai'aishen Biotechnology Co., Ltd. and Youzhicun (Guangzhou) Biotechnology Co., Ltd.
The deeper causes behind this scandal that tears at the industry's ethical foundation go far beyond ordinary quality control lapses. Rather, they stem from a brutal arbitrage strategy adopted by certain traditional daily chemical processing plants at the bottom of the supply chain—faced with intense e-commerce price wars and the financial anxiety of suffocating free cash flow—that involved substituting toxic, hazardous light-asset chemical alternatives to squeeze out marginal profits at the edges.
In conventional consumer consensus, wild self-media outlets tend to frame such incidents as run-of-the-mill "corner-cutting," dismissing white-label mosquito repellent as merely suffering from "insufficient concentration or reduced efficacy"—a minor flaw. But the media's pixel-level scrutiny has peeled back the layers to reveal a more sobering and bloodier truth. Factories like Bai'aishen, fully aware of the toxicity risks, illegally added excessive amounts of low-grade pesticide ingredients and counterfeit chemical raw materials—unregistered with national agricultural authorities and even explicitly banned—into infant-grade mosquito repellent patches and sprays. This tactic of packaging "high-risk toxins" as "green and all-natural" through lightweight marketing spin is, in essence, using the health of minors with underdeveloped immune systems as leverage to offset their own utter lack of core R&D and production capabilities. The sheer viciousness of these methods amounts to nothing less than a calculated act of commercial poisoning in peacetime.
As public outrage floods in like an unstoppable tide, the corporate shells behind these hidden toxins had already been riddled with holes on the regulatory radar within the compliance framework of the business registration system.
Tianyancha App shows that the implicated company, Guangzhou Bai'aishen Biotechnology Co., Ltd., was established in March 2009, with legal representative Li Shengguo, registered capital of 7.58 million RMB, and a business scope covering cosmetics manufacturing, soap and synthetic detergent manufacturing, oral cleaning products manufacturing, among others. According to the shareholding structure disclosed by Tianyancha, the company is jointly held by Yang Zifeng, Zhang Lanrong, and Li Shengguo.
What best strips away its facade is the long scroll of operational risks flashing red alerts on Tianyancha: the company has multiple existing administrative penalty records, with the penalty reasons highly concentrated on quality violations in daily chemical products, and all these iron-fisted fines were issued by the Guangzhou Baiyun District Market Supervision Administration.
These historical penalty records sitting quietly in the Tianyancha files completely puncture the so-called "compliant internal controls" of this daily chemical giant with nearly two decades of history.
They clearly show that Bai'aishen, when facing market regulation, has long perfected a weary defiance of "a dead pig unafraid of scalding water." The frequent quality violation records appearing on Tianyancha indicate that this company has long been harvesting consumers on major e-commerce platforms through shell workshops. When hit with administrative penalties from local market regulators, it simply treated fines of tens of thousands to hundreds of thousands of RMB as routine "toll fees" and compliance wear-and-tear. This crude approach of converting legal authority into operating costs built a short-term financial firewall. But when CCTV's targeted strike and national-level regulatory task forces tightened the screws completely, the blemishes accumulated over years on Tianyancha instantly transformed from scattered administrative adjustments into an iron noose that strangled the company's entire credit assets and corporate sovereignty into extinction.
Business evolution has always been ruthless. In the end-of-2026 melee where survival is defined by full-channel penetrating audits, absolute compliance, and real consumer data, the era of squeezing marginal profits through toxic loopholes and undermining public health safety has already been declared over ahead of schedule.
The latest penalty record left on Tianyancha by Bai'aishen and Youzhicun serves as a definitive ultimatum that white-label and off-brand manufacturers must not cross the red line of life. This scandal sounds the death knell for all traditional workshops attempting to offset cost pressures through edge-case substitutes: when the digital supply chain audit net and the iron fist of the rule of law converge with pixel-level precision, no shell entity can secure permanent immunity. Any machine that dares to challenge compliance boundaries will face the brutal cost of being uprooted and driven out entirely under even tighter targeted enforcement.
